Shell beats expectations with $10.8 billion third-quarter profit

More in Business

• STAT+: Biopharma industry at odds over impact of Treasury’s new China rule

  Proposed curbs from the Treasury Department seek to restrict American capital from funding Chinese biotechnology entities. Sector leaders are currently assessing the practical reach of the measure, which surfaced as more aggressive than anticipated. A targeted carve-out for licensing agreements has triggered debate over whether the policy will genuinely hinder Chinese competition or leave substantial avenues open.

  1 min read
• Singapore, Cambodia police and OCBC help Singapore company recover US$12.8 million from scammers

  A Singapore-based petrochemical firm was targeted after fraudsters spoofed a partner's email address and provided a forged authorization letter to divert funds overseas. Cross-border law enforcement intervention alongside bank officials successfully halted the loss and returned the entirety of the hijacked capital. The case demonstrates the critical role rapid reporting plays in clawing back stolen enterprise assets across jurisdictions.

  1 min read
• Fluidra narrows 2026 guidance after third quarter results

  Executive management refined the multi-year strategic targets to account for current operational momentum and evolving demand trends. The pool equipment manufacturer updated these financial projections immediately following its third quarter performance review. This calibration offers shareholders a more precise trajectory for long-term growth and capital planning.

  1 min read